期刊文献+

培垛普利对冠心病患者经皮冠状动脉介入术后肱动脉内皮功能障碍的影响 被引量:1

Influence of perindopril on percutaneous coronary intervention-induced brachial artery endothelial dysfunction in coronary artery disease patients
下载PDF
导出
摘要 目的探讨培垛普利对经皮冠状动脉介入(PCI)操作所诱发的肱动脉内皮功能不全的影响。方法实行PCI的冠心病患者62例,随机分为2组,培垛普利组31例,对照组31例,应用高频超声探头分别测量2组PCI术前及术后的肱动脉基础内径、反应性充血内径、含服硝酸甘油后内径,计算肱动脉血流介导的舒张反应(FMD),并运用多普勒技术测定血流速度峰值,最后比较2组间及组内上述参数的差异。超声测量于PCI术前2h和术后30min内完成。结果培垛普利组的FMD明显改善〔(5.9±0.3)%术前vs(7.7±0.4)%术后PCI,P<0.001〕,而对照组明显恶化〔(6.0±0.5)%术前vs(4.8±0.6)%术后PCI,P<0.001〕。两组硝酸甘油介导的血管舒张反应及反应性充血血流速度峰值均无明显变化。结论培垛普利可改善PCI介导的肱动脉内皮功能不全。 Objective To investigate the influence of perindopril on endothelial dysfunction of the brachial artery induced by percutaneous coronary intervention (PCI). Methods Sixty-two patients with coronary artery disease who underwent elective PCI were randomly divided into two groups: perindopril group(n= 31) and control group(n= 31). The baseline diameter of brachial artery, the reactive hyperemia diameter and the diameter after sublingual nitro- glycerin (NTG) before and after PCI were respectively examined by high-resolution ultrasonic transducer and flow-mediated dilation (FMD) as the percent change in the brachial artery in response to hyperemia was calculated. At the same time, the maximum blood flow velocity at rest and during reaetive hyperemia was also determined by pulsed-Doppler signals. The above parameters were respectively compared in two groups and between groups. All patients were examined within 2h before and within 30 min after completion of PCI. Results Perindopril significantly im proved FMD[(5. 9±0. 3)% before vs (7.7±0.4)% after PCI, P〈0. 0013, whereas there was impaired FMD in the patients of the control group[(6.0±0.5)% before vs (4.8±0.6)% after PCI, P〈0. 0013. The vasodilation reaction induced by NTG and the maximum blood flow velocity of reactive hyperemia in the two groups remained unaltered. Conclusion Perindopril can improve endothelial dysfunction of the brachial artery during PCI.
出处 《中华老年多器官疾病杂志》 2009年第1期35-38,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 培垛普利 血管成形术 经腔 经皮冠状动脉 肱动脉 冠状动脉疾病 perindopril percutaneous transluminal coronary angioplasty brachial artery coronary disease
  • 相关文献

参考文献12

  • 1Kuvin JT,Patel AR,Sline KA.Peripheralvascular endothelial function testing as a noninvasive indicator of coronary arterydisease.J Am Coil Cardiol,2001,38:1843-1849.
  • 2Gokce N,Keaney JF Jr,Hunter LM.Risk stratification for postoperative cardiovascularevents via noninvasire assessment of endothelial function:prospectivestudy.Circulation,2002,105:1567-1572.
  • 3Warnholtz A,Ostad MA,Heitzer T.Effect of tirofiban on percutaneous coronaryintervention-induced endothelial dysfunction in patients with stable coronary arterydisease.Am J Cardiol,2005,95:20-23.
  • 4Kovacs I,Toth J,Tarjan J.Correlation of flow mediated dilation with inflammatorymarkers in patients with impaired cardiac function.Beneficial effects of inhibition ofACE.Eur J Heart Fail,2006,8:451-459.
  • 5Heltianu C,Costache G,Gafeneu A.Relationship of eNOS gene variants to diseases thathave in common an endothelial cell dysfunction.J Cell Mol Med,2005,9:135-142.
  • 6Coretti MC,Anderson TJ,Benjamin EJ.Guidelines for the ultrasound assessment ofendothelial-dependent-mediated vasodilation of the brachial artery:a report of theinternational brachial artery reactivity task force.J Am COll Cardiol,2002,39:257-265.
  • 7高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,30(12):707-718. 被引量:336
  • 8张燕,刘鹏,李靖.替罗非班对冠心病PCI术中内皮功能障碍影响的研究[J].中国误诊学杂志,2006,6(16):3069-3071. 被引量:8
  • 9Ryszard JG,Stefan C,Wojciech U.Significance of endothelial prostacyclin and nitricoxide in peripheral and pulmonary circulation.Med Sci Monit,2001,7:1-16.
  • 10Stefan C,Ryszard JG.Angiotensin converting enzyme (ACE) and hydroxymethylglutaryl-CoA(HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.PharmacoRep,2005,57 (Suppl):86-96.

二级参考文献8

  • 1Takase B,Uehata A,Akima T,et al.Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease[J].Am J Cardiol,1998,82(12):1535-1539,A7-A8.
  • 2Kuvin JT,Patel AR,Sline KA,et al.Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease[J].J Am Coll Cardiol,2001,38(7):1843-1849.
  • 3Gokce N,Keaney JF Jr,Hunter LM,et al.Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:p prospective study[J].Circulation,2002,105(13):1567-1572.
  • 4Heitzer T,Ollmann I,Koke K,et al.Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease[J].Circulation,2003,108(5):536-541.
  • 5Coretti MC,Anderson TJ,Benjamin EJ,et al.Guidelines for the ultrasound assessment of endothelial-dependent-nediated vasodilation of the brachial artery:a report of the international brachial artery reactivity take force[J].J Am Coll Cardiol,2002,39(2):257-265.
  • 6Leclerc JR.Platelet glycoprotein Ⅱb/Ⅲa antagonists lessons learned from clinical trials and futute directions[J].Crit Care Med,2002,30(5 Suppl):S332-S340.
  • 7Sheu JR,Yen MH,Hung WC,et al.Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta[J].Arterioscler Thromb VascBiol,1997,17(12):3461-3468.
  • 8高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,30(12):707-718. 被引量:336

共引文献342

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部